Endotoxin as a factor in adverse reactions to latex gloves

Annals of Allergy, Asthma and Immunology

Volumn 79, Issue 4, 1997, Pages 303-310

  Williams, P Brock ^a   Halsey, John F ^a  

^a IBT Reference Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; LATEX;

ALLERGENICITY; ARTICLE; DELAYED HYPERSENSITIVITY; ENDOTOXEMIA; HUMAN; IMMUNOGLOBULIN PRODUCTION; IMMUNOPATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; RADIOALLERGOSORBENT TEST; SURGICAL GLOVE;

EID: 0030782732     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63019-0     Document Type: Article

References (59)

1. Raetz CRH, Ulevitch RJ, Wright SD, et al. Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J 1991;5:2652-60.
2. Rietschel ET, Schade U, Jensen M, et al. Bacterial endotoxins: chemical structure, biological activity and role in septicaemia. Scand J Infect Dis Suppl 1982;31:8-21.
3. Hoekstra D, Van Der Laan JW, DeLeij L, Witholt B. Release of outer membrane fragments from normally growing Escherichia coli. Biochim Biophys Acta 1976;455:889-99.
4. Cadieux JE, Kuzio J, Milazzo FD, Kropinski AM. Spontaneous release of lipopolysaccharide by Pseudomonas aeruginosa. J Bacteriol 1983;155: 817-25.
5. Shenep JI. Antibiotic-induced bacterial cell lysis: a therapeutic dilemma. Eur J Clin Microbiol 1986;5:11-20.
6. Wright SD, Ramos RA, Tobias PS, et al. CD14: a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990;249: 1431-3.
7. Tobias PS, Mathison JC, Ulevitch RJ. A family of lipopolysaccharide binding proteins involved in responses to gram negative sepsis. J Biol Chem 1988;263:13479-81.
8. Tobias PS, Soldau K, Ulevitch RJ. Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. J Biol Chem 1989;264:10867-71.
9. Beutler B, Cerami A. The biology of cachectin/TNF-a primary mediator of the host response. Annu Rev Immunol 1989;7:625-55.
10. Nordan R, Potter M. A macrophage-derived factor required for plasmacytomas for survival and proliferation in vitro. Science 1986;233:566-9.
11. Pober JS, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev 1990;70:427-51.
12. Pohlman TH, Harlan JM. Endotoxin-endothelial cell interactions. In: Morrison DC and Ryan J, ed. Bacterial endotoxic lipopolysaccharides. Boca Raton: CRC Press, 1992:459-72.
13. Piguet PF, Grau GE, Hauser C, Vassalli P. Tumor necrosis factor is a critical mediator in hapten-induced irritant and contact hypersensitivity. J Exp Med 1991;173:673-9.
14. Milton DK, Amsel J, Reed CE, et al. Cross-sectional follow-up of a flu-like respiratory illness among fiberglass manufacturing employees: endotoxin exposure associated with two distinct sequelae. Am J Ind Med 1995;28: 469-88.
15. Casale TB, Bailas ZK, Kaliner MA, Keahey TM. The effects of intravenous endotoxin on various host-effector molecules. J Allergy Clin Immunol 1990;85:45-51.
16. Sandstrom T, Bjermer L, Rylander R. Lipopolysaccharide (LPS) inhalation in healthy subjects increases neutrophils, lymphocytes and fibronectin levels in bronchoalveolar lavage fluid. Eur Respir J 1992;5:992-6.
17. Sandstrom T, Bjermer L, Rylander R. Lipopolysaccharide (LPS) inhalation in healthy subjects causes bronchalveolar neutrophilia, lymphocytosis, and fibronectin increase. Am J Ind Med 1994;25:103-4.
18. Michel O, Duchateau J, Sergysels R. Effects of inhaled endotoxin on bronchial reactivity in asthmatic and normal subjects. J Appl Physiol 1989;66: 1059-64.
19. Galanos CMA, Freudenberg, Matsuura M. Mechanisms of the lethal action of endotoxin and endotoxin hypersensitivity. In: Friedman H, Klein TW, Nakona M, Nowotny A, ed. Endotoxin. New York: Plenum Press, 1990: 603-19.
20. Takada H, Kawabata Y, Kawata S, Kusumoto S. Structural characteristics of peptidoglycan fragments required to prime mice for induction of anaphylactoid reactions by lipopolysaccharides. Infect Immun 1996;64:657-9.
21. Baker PJ, Hrada T, Taylor CF, et al. Structural features that influence the ability of lipid A and its analogs to abolish expression of suppressor T cell activity. Infect Immun 1992;60: 2694-701.
22. Millar A, Singer M, Meager A, et al. Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet 1989;2:712-5.
23. Jacobs CO, Fronek Z, Lewis GD, et al. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor α: Relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990;87: 1233-7.
24. Li ZG, Danis VA, Brooks PM. Effect of gonadal steroids on the production of Il-1 and I1-6 by blood mononuclear cells in vitro. Clin Exp Rheumatol 1993;11:157-62.
25. Snapper C, Peca-nha L, Levine A, Mond J. IgE class switching is critically dependent upon the nature if the B-cell activator, in addition to the presence of Il-4. J Immunol 1991;147: 1163-70.
26. Coffman RL, Ohara J, Bond MW, et al. B cell stimulatory factor-1 enhances the IgE response of LPS activated B cells. J Immunol 1986;136:4538-45.
27. Mizoguchi K, Nakashima Y, Hasegawa K. Augmentation of antibody responses of mice to inhaled protein antigens by simultaneously inhaled bacterial polysaccharide. Immunobiology 1986;34:355-65.
28. Bottaro A, Lansford R, Xu L, et al. S region transcription per se promotes basal IgE class switch recombination but additional factors regulate the efficiency of the process. EMBO J 1994; 13:665-74.
29. Smith TF, Alvelot M, Morrison DC. The effect of bacterial lipopolysaccharide on histamine release from human basophils. I. Enhancement of immunologie release by S. minnesota R595 LPS. Clin Immunopath 1985;34: 355-65.
30. Norm S. Microorganism-induced or enhanced mediator release: a possible mechanism in organic dust related diseases. Am J Ind Med 1994;25:91-5.
31. Iida M, Shinohara S, Yamaguchi M, et al. Lipopolysaccharide primes human basophils for enhanced mediator release: requirement for plasma cofactor and CD-14. Biochem Biophys Res Comm 1994;203:1295-301.
32. Norm S, Jarlov J, Clementsen P, et al. Bacteria and their products peptidoglycan and teichnoic acid potentiate antigen-induced histamine release in allergic patients. Agents Action 1987;20: 175-7.
33. Dillard SF, MacCollum MA. Reports to the FDA: allergic reactions to latex containing medical devices. International Latex Conference: Sensitivity to latex in medical devices [Abstract]. 1992:23.
34. Sussman GL, Tarlo S, Dolovitch J. The spectrum of IgE-mediated responses to latex. JAMA 1991;265: 2844-7.
35. Turjanmaa K, Alenius H, MakinenKiljunen S, et al. Natural rubber latex allergy. Allergy 1996;51:593-602.
36. Ownby D, Tomlanovitch M, Sammons N, McCullough J. Fatal anaphylaxis during a barium enema examination associated with latex allergy. Am J Roentgenol 1991;156:903-8.
37. Jaeger D, Kleinhans D, Czuppon AB, Baur X. Latex specific proteins causing immediate-type cutaneous, nasal, bronchial, and systemic reactions. J Allergy Clin Immunol 1992;89: 759-68.
38. Kaniwa M, Isama K, Nakamura A, et al. Identification of causitive chemicals of allergic contact dermatitis using a combination of patch testing in patients and chemical analysis. Application to cases from rubber gloves. Contact Dermatitis 1994;31:65-71.
39. Slater JE. Latex allergy. J Allergy Clin Immunol 1994;94:139-49.
40. Yagami T, Sato M, Nakamura A, Shono M. One of the rubber latex allergens is a lysozyme. J Allergy Clin Immunol 1995;96:677-86.
41. Alenius H, Kurup V, Kelly K, et al. Latex allergy: frequent occurrence of IgE antibodies to a cluster of 11 latex proteins with spina bifida and histories of anaphylaxis. J Lab Clin Med 1994; 123:712-20.
42. Alenius H, Kalkkinen N, Turjanmaa K, et al. Purification and partial amino acid sequencing of a 27 kD natural rubber allergen recognized by latex-allergic children with spina bifida. Int Arch Allergy Immunol 1995;106: 258-62.
43. Alenius H, Kalkkinen N, Reunala T, et al. The main IgE-binding epitope of a major latex allergen, prohevein, is present in its N-terminal 43-amino acid fragment, Hevein. J Immunol 1996;156:1618-25.
44. Lu LJ, Kurup VP, Huffman DR, et al. Characterization of a major latex allergen associated with hypersensitivity in spina bifida patients. J Immunol 1995; 155:2721-8.
45. Kurup VP, Kelly T, Elms N, et al. Cross-reactivity of food allergens in latex allergy. Allergy Proc 1994;15: 211-6.
46. Czuppon AB, Chen Z, Rennert S, et al. The rubber elongation factor of rubber tree (Hevea brasiliensis) is the major allergen in latex. J Allergy Clin Immunol 1993;92:690-7.
47. Lavaud F, Prevost A, Cossart C, et al. Allergy to latex, avocado, pear, and bananna: evidence for a 30 kD antigen in immunoblotting. J Allergy Clin Immunol 1995;95:557-64.
48. Sussman GL, Beezhold DH. Allergy to latex rubber. Ann Intern Med 1995; 122:43-6.
49. Halsey JF. Reports to the FDA: measurement of the latex allergen content in medical devices. International latex conference: sensitivity to latex in medical devices [Abstract]. 1992:24.
50. Tomazic VJ, Withrow TJ, Hamilton RG. Allergens, IgE mediators, inflammatory mechanisms. Characterization of the allergen(s) in latex protein extracts. J Allergy Clin Immunol 1995; 96:635-42.
51. Tomazic VJ, Shampaine EL, Lamanna A, et al. Cornstarch powder on latex products is an allergen carrier. J Allergy Clin Immunol 1994;93:751-8.
52. Douwes J, Versloot P, Hollander A, et al. Influence of various dust sampling and extraction methods on the measurement of airborne endotoxin. Appl Environ Microbiol 1995;61:1763-9.
53. Yunginger JW, Jones RT, Fransway AF, et al. Extractable latex allergens and proteins in disposable medical gloves and other rubber products. J Allergy Clin Immunol 1994;93: 836-42.
54. Warren JB, Coughlan ML, Williams TJ. Endotoxin-induced vasodilatation in anaesthetized rat skin involves nitric oxide and prostaglandin synthesis. Br J Pharmacol 1992;106:953-7.
55. Rylander R, Beijer L. Inhalation of endotoxin stimulates alveolar macrophage production of platelet-activating factor. Am Rev Respir Dis 1987;135: 83-6.
56. Beebe RG, Sullivan TJ. Analysis of clinical indicators of IgE-mediated occupational latex allergy [Abstract]. Ann Allergy Asthma Immunol 1997; 78:86.
57. Castellan RM, Olenchock KB, Kinsley KB, Hankinson JL. Inhaled endotoxin and decreased spirometric values, an exposure-response relation for cotton dust. N Engl J Med 1987;317:605-10.
58. Rylander R, Haglind P, Lundholm M. Endotoxin in cotton dust and respiratory function decrement among cotton workers in an experimental cardroom. Am J Respir Dis 1985;131:209-13.
59. Arellano R, Bradley J, Sussman G. Prevalence of latex sensitization among hospital physicians occupationally exposed to latex gloves. Anesthesiology 1992;77:905-8.